Diaceutics Group leverages analytics, software, services and strategy to enable the effective integration of therapies and diagnostics into the treatment pathway.
Diaceutics AIS integrates the planning, analytical and action steps needed for the successful development and commercialization of testing for targeted therapies.
Labceutics leverages the
Laboratory – Physician Interface globally to integrate companion
and complementary tests into personalized medicine.
Iceutics provides pharma and diagnostic executives open source access to many of the expert integrated resources in personalized medicine underpinning the
Diaceutics Method ®
Bioceutics helps pharma integrate the diagnostic into communications, enabling ownership of the testing moment and the establishment of personalized medicine as an additional marketing pillar alongside efficacy, safety, cost and convenience.
Diaceutics Group

Diaceutics’ acclaimed open access Pharma Readiness reports benchmark the competitive landscape in personalized medicine.

These ’unique integration events’ bring together expert stakeholders from across personalized medicine. Our fifth Convergence took place September 15-16, 2015 in Philadelphia, USA.

Partnering with key PM stakeholders, we are working to create and implement a multi-stakeholder business model in the areas of malignant melanoma and early onset asthma.

Designed for therapy and diagnostic teams, Diaceutics Method ® helps navigate the complexities of combining testing and therapy into a treatment pathway.

PM Equals